Boundless Bio, Inc.
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell BOLD and other ETFs, options, and stocks.About BOLD
Boundless Bio, Inc. is a clinical-stage oncology company, which is dedicated to unlocking a new paradigm in cancer therapeutics that addresses the significant unmet need in patients with oncogene amplified tumors by targeting extrachromosomal DNA. The company was founded by Vineet Bafna, Paul Mischel, Benjamin F.
BOLD Key Statistics
Stock Snapshot
With a market cap of 25.3M, Boundless Bio, Inc.(BOLD) trades at $1.13. The stock has a price-to-earnings ratio of -0.41.
On 2026-03-05, Boundless Bio, Inc.(BOLD) stock moved within a range of $1.13 to $1.16. With shares now at $1.13, the stock is trading 0.0% above its intraday low and -2.6% below the session's peak.
Trading volume for Boundless Bio, Inc.(BOLD) stock has reached 12.39K, versus its average volume of 55.09K.
The stock's 52-week range extends from a low of $0.96 to a high of $1.83.
The stock's 52-week range extends from a low of $0.96 to a high of $1.83.
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.